Rabbit IgG FRET-PINCER® Assay Kit, 384-well format

rabbit IgG RI-1015-384

Clear selection



Mediomics’ rabbit immunoglobulin G (rIgG) FRET-PINCER® assay kit can be used to quantitatively detect the concentration of rIgG in biological samples.

Immunoglobulin G (IgG) is the most abundant immunoglobulin in serum, and it is a biomarker of the adaptive immune response. Immunoglobulin levels can vary with health status, age, and drug treatment; therefore, quantitative measurements are a useful tool for pre-clinical researchers.  Overabundance or, conversely, an absence of a certain specific subclass may be associated with disease.


Product applications:

1. Drug and vaccine testing to identify the presence/absence of an adaptive immune response.

2. Rapid detection of rIgG antibodies in a pull-down or co-IP assay.

3. Detection of rIgG concentration within biological samples as part of a pre-clinical research program.


Product Advantage:

Mediomics’ rIgG FRET-PINCER® assay is ideally suited for the rapid, simultaneous measurement of rabbit IgG levels in large number of test samples due to its speed and simplicity. It is readily adaptable to the high-throughput screening platforms currently being used in drug discovery research.

 h Insulin Assay Pic

In comparison to the ELISA procedure, the FRET-PINCER® technology provides a simple (one mixing step) and fast (30 minute incubation) assay that is quantitative and reproducible.

rIgG std curve

Limit of Detection (LOD): 7.8 ng/mL

CV value: < 2.6%

Detection Range: 7.8 – 500 ng/mL (Note: The upper limit can be expanded by Mediomics’ assay design experts. Please contact us for assistance.)

Cross reactivity: There is no cross reactivity with mouse IgG, mouse IgM or human IgG.


Pricing: The 100-well kit is a one-time trial purchase. For bulk pricing options, please contact us. For any other questions or comments, please do not hesitate to contact us. We are always happy to help!


Please refer to our technology pages for information on the scientific principles and technological advancements of the FRET-PINCER® assays.


  1. PINCER® is a registered trademark of Mediomics, LLC, St. Louis, Missouri, U.S.A. Mediomics has a worldwide, exclusive license for this assay platform from Saint Louis University, St. Louis, Missouri.

  2. The FRET-PINCER®  Assay kit is provided for laboratory R&D use only. This product is not approved by the U.S. Government or by the government of any other country of the world for use in the clinical diagnosis of disease, or treatment of disease in humans or animals.

  3. Patents allowed and pending in the U.S. and abroad.

  4. PINCER® products have been developed with support, in part, from the National Institutes of Health, through STTR Phase I and Phase II Grants.


Catalog #: RI1015-100 , RI1015-384